Clincosm LogoSign in Get a demo

multiple myeloma

Showing NaN - NaN of 99
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Belgium, France, United States (EOS884448, Iberdomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
  • +3 more
Jun 15, 2022

Multiple Myeloma Trial in Hackensack (Daratumumab, Pomalidomide, All-trans retinoic acid)

Recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
    John Theurer Cancer Center
Jun 10, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Durvalumab, Pomalidomide)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +43 more
Jun 9, 2022

Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

Active, not recruiting
  • Multiple Myeloma
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +8 more
May 24, 2022

Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Denver, Colorado
  • +8 more
May 19, 2022

Multiple Myeloma Trial in Hackensack (Fludarabine monophosphate, melphalan, Bortezomib)

Completed
Has Results
  • Multiple Myeloma
  • Fludarabine monophosphate, melphalan, Bortezomib
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Apr 29, 2022

Multiple Myeloma Trial in United States (P-BCMA-101 CAR-T cells, Rimiducid)

Terminated
  • Multiple Myeloma
  • Gilbert, Arizona
  • +15 more
May 17, 2022

Multiple Myeloma Trial in Washington, Hackensack (Melphalan, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Washington, District of Columbia
  • +1 more
May 6, 2022

Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Venetoclax)

Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +39 more
Mar 2, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Multiple Myeloma Trial in Washington, Hackensack (Selinexor 60 MG, Selinexor 80 MG, Selinexor 100 MG)

Recruiting
  • Multiple Myeloma
  • Selinexor 60 MG
  • +6 more
  • Washington, District of Columbia
  • +1 more
Feb 3, 2022

Multiple Myeloma Trial in Hackensack (Pembrolizumab, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
    John Theurer Cancer Center-Hackensack Meridian Health
Jan 18, 2022

Lung Cancer, Solid Tumor, Gastric Cancer Trial in Denmark, United States (Pemigatinib, Gemcitabine + Cisplatin, Pembrolizumab)

Completed
  • Lung Cancer
  • +10 more
  • Birmingham, Alabama
  • +19 more
Jan 4, 2022

Multiple Myeloma Trial in United States (Lenalidomide, Elotuzumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Atlanta, Georgia
  • +6 more
Dec 17, 2021

Multiple Myeloma Trial in United States (Lenalidomide, lenalidomide, bortezomib and dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tucson, Arizona
  • +53 more
Dec 8, 2021

Multiple Myeloma, Lymphoma Trial in Washington, Hackensack (Ipilimumab, Nivolumab)

Active, not recruiting
  • Multiple Myeloma
  • Lymphoma
  • Washington, District of Columbia
  • +1 more
Dec 2, 2021

Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)

Terminated
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia
  • Scottsdale, Arizona
  • +18 more
Nov 15, 2021

Multiple Myeloma Trial in United States (procedure, drug, behavioral)

Completed
Has Results
  • Multiple Myeloma
  • One Autologous Transplant
  • +5 more
  • Birmingham, Alabama
  • +35 more
Oct 19, 2021

Multiple Myeloma Trial in Hackensack (Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Vorinostat, Lenalidomide, Carfilzomib, Dexamethasone
  • Hackensack, New Jersey
    Hackensack University Medical Center
Oct 4, 2021

Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in France, Netherlands, United States (AMG 232)

Completed
  • Advanced Malignancy
  • +7 more
  • AMG 232
  • Santa Monica, California
  • +13 more
Aug 30, 2021

Multiple Myeloma Trial in United States (hLL1-DOX (the doxorubicin conjugate of milatuzumab))

Terminated
  • Multiple Myeloma
  • hLL1-DOX (the doxorubicin conjugate of milatuzumab)
  • Orlando, Florida
  • +4 more
Aug 12, 2021

Multiple Myeloma, Myeloma, Plasma-Cell, PLASMACYTOMA Trial in United States (milatuzumab)

Completed
  • Multiple Myeloma
  • +2 more
  • milatuzumab
  • Atlanta, Georgia
  • +5 more
Aug 12, 2021

Multiple Myeloma Trial in Worldwide (Durvalumab, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
  • +34 more
Aug 4, 2021

Multiple Myeloma Trial in Germany, United States (LBH589)

Terminated
Has Results
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +28 more
Jun 22, 2021

Multiple Myeloma, NonHodgkin Lymphoma Trial in United States (TAS4464)

Terminated
  • Multiple Myeloma
  • NonHodgkin Lymphoma
  • Bethesda, Maryland
  • +6 more
Jun 18, 2021